Healthcare resource use and costs of diabetic macular oedema for patients with antivascular endothelial growth factor versus a dexamethasone intravitreal implant in Korea: a population-based study

OBJECTIVES: To estimate the costs and healthcare resources of patients with diabetic macular oedema (DME) who received intravitreal antivascular endothelial growth factor (anti-VEGF) agents or a dexamethasone intravitreal implant (DEX-implant) in Korea. DESIGN: Retrospective cohort study. SETTING: T...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, HyunJeong, Choi, Kyung Seek, Lee, Joo Yong, Lee, Donghwan, Choi, Nam-Kyong, Lee, YouKyung, Bae, SeungJin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756349/
https://www.ncbi.nlm.nih.gov/pubmed/31542758
http://dx.doi.org/10.1136/bmjopen-2019-030930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756349/
https://www.ncbi.nlm.nih.gov/pubmed/31542758
http://dx.doi.org/10.1136/bmjopen-2019-030930

Ejemplares similares